ARYEH JASON sold 4.6% of their position (5K shares) of LIGAND PHARMACEUTICALS INC on the open market
Open‑market sale worth $1.25M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 6/12/2026ACC: 0002001011-26-000103
-1.23K
Net shares
Net seller
$1.25M
Total sold
2
Open market trades
0B · 2S
4
Total transactions
3.77K acquired · 5K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+836.00
Price / share
—
Trade value
—
% of position
0.8%
6/5/2026
106.74K→107.58K
Common Stock
Direct
Shares
−500.00
Price / share
$250.00
Trade value
$125K
% of position
0.5%
6/10/2026
107.58K→107.08K
Common Stock
Direct
Shares
−4.50K
Price / share
$250.00
Trade value
$1.13M
% of position
4.2%
6/11/2026
107.08K→102.58K
Total
Net shares
−4.16K
Net value
-$1.25M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/5/2026 | A · Award | +836.00 | — | — | 0.8% | 106.74K | 107.58K |
| Common Stock Direct | 6/10/2026 | S · Sale | −500.00 | $250.00 | $125K | 0.5% | 107.58K | 107.08K |
| Common Stock Direct | 6/11/2026 | S · Sale | −4.50K | $250.00 | $1.13M | 4.2% | 107.08K | 102.58K |
| Total | −4.16K | -$1.25M | ||||||
Derivative Transactions1
Non-Qualified Stock Option (right to buy)
Direct
Converts to
Common Stock
2.94K shares
Shares
+2.94K
Strike price
237.0
Held after
2.94K
Exercisable
—
6/5/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy) Direct | Common Stock2.94K shares | 6/5/2026 | A · Award | +2.94K | 237.0 | — | 2.94K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned13K
Total
13K indirect13K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 13K | Indirect |
| Total | 13K | 13K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported